p53表位的自身抗体识别机制
Autoantibody recognition mechanisms of p53 epitopes
摘要:
迫切需要经济的基于血液的非侵入性分子生物标志物,以在早期阶段以成本有效的方式辅助癌症的检测和诊断,此时治疗性干预仍然是可能的。血清自身抗体是早期癌症检测的有吸引力的生物标志物,但它们的发展受到一千万已知癌症突变的间断遗传性质的阻碍。最近对50,000名患者的研究(Pedersen等人,2013)显示p53 15 mer表位是比p53更敏感的结肠癌生物标志物,而p53又是比任何其他蛋白质更敏感的癌症生物标志物。p53作为一种几乎通用的肿瘤抑制因子的功能已经得到了很好的确立,因为它不仅在抗体募集方面具有很强的免疫原性,而且还能刺激自身抗体。在这里,我们研究了生物信息学分形尺度分析,从p53氨基酸序列中识别敏感表位,并展示了它如何用于早期癌症检测(ECD)。我们将15聚体修剪为7聚体,并从其他物种中鉴定出对侵袭性人类癌症(如肝癌)更敏感的特定7聚体。
英文摘要:
There is an urgent need for economical blood based, noninvasive molecular biomarkers to assist in the detection and diagnosis of cancers in a cost effective manner at an early stage, when curative interventions are still possible. Serum autoantibodies are attractive biomarkers for early cancer detection, but their development has been hindered by the punctuated genetic nature of the ten million known cancer mutations. A recent study of 50,000 patients (Pedersen et al., 2013) showed p53 15mer epitopes are much more sensitive colon cancer biomarkers than p53, which in turn is a more sensitive cancer biomarker than any other protein. The function of p53 as a nearly universal tumor suppressor is well established, because of its strong immunogenicity in terms of not only antibody recruitment, but also stimulation of autoantibodies. Here we examine bioinformatic fractal scaling analysis for identifying sensitive epitopes from the p53 amino acid sequence, and show how it could be used for early cancer detection (ECD). We trim 15mers to 7mers, and identify specific 7mers from other species that could be more sensitive to aggressive human cancers, such as liver cancer.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。